Beatriz Sánchez-Nieto1, Maite Romero-Expósito2, José A Terrón3, Francisco Sánchez-Doblado4. 1. Instituto de Física, Pontificia Universidad Católica de Chile, Av. Vicuña Mackenna 4880, Macul, Santiago, Chile. Electronic address: bsanchez@fis.puc.cl. 2. Departament de Física, Universitat Autònoma de Barcelona, Edifici C, Campus UAB E-08193, Bellaterra, Spain. Electronic address: mariateresa.romero@uab.cat. 3. Servicio de Radiofísica, Hospital Universitario Virgen Macarena, Av. Doctor Fedriani, 3, 41009 Sevilla, Spain. Electronic address: jose.terron.sspa@juntadeandalucia.es. 4. Servicio de Radiofísica, Hospital Universitario Virgen Macarena, Av. Doctor Fedriani, 3, 41009 Sevilla, Spain; Departamento de Fisiología Médica y Biofísica, Universidad de Sevilla, Av. Doctor Fedriani S/N, 41009 Sevilla, Spain. Electronic address: paco@us.es.
Abstract
PURPOSE: Biological treatment plan evaluation does not currently consider second cancer induction from peripheral doses associated to photon radiotherapy. The aim is to propose a methodology to characterize the therapeutic window by means of an integral radiobiological approach, which considers not only Tumour Control Probability (TCP) and Normal Tissue Complication Probability (NTCP) but also Secondary Cancer Probability (SCP). METHODS: Uncomplicated and Cancer-Free Control Probability (UCFCP) function has been proposed assuming a statistically uncorrelated response for tumour and normal tissues. The Poisson's and Lyman's models were chosen for TCP and NTCP calculations, respectively. SCP was modelled as the summation of risks associated to photon and neutron irradiation of radiosensitive organs. For the medium (>4Gy) and low dose regions, mechanistic and linear secondary cancer risks models were used, respectively. Two conformal and intensity-modulated prostate plans at 15MV (same prescription dose) were selected to illustrate the UCFCP features. RESULTS: UCFCP exhibits a bell-shaped behaviour with its maximum inside the therapeutic window. SCP values were not different for the plans analysed (∼2.4%) and agreed with published epidemiological results. Therefore, main differences in UCFCP came from differences in rectal NTCP (18% vs 9% for 3D-CRT and IMRT, respectively). According to UCFCP values, the evaluated IMRT plan ranked first. CONCLUSIONS: The level of SCP was found to be similar to that of NTCP complications which reinforces the importance of considering second cancer risks as part of the possible late sequelae due to treatment. Previous concerns about the effect of peripheral radiation, especially neutrons, in the induction of secondary cancers can be evaluated by quantifying the UCFCP.
PURPOSE: Biological treatment plan evaluation does not currently consider second cancer induction from peripheral doses associated to photon radiotherapy. The aim is to propose a methodology to characterize the therapeutic window by means of an integral radiobiological approach, which considers not only Tumour Control Probability (TCP) and Normal Tissue Complication Probability (NTCP) but also Secondary Cancer Probability (SCP). METHODS: Uncomplicated and Cancer-Free Control Probability (UCFCP) function has been proposed assuming a statistically uncorrelated response for tumour and normal tissues. The Poisson's and Lyman's models were chosen for TCP and NTCP calculations, respectively. SCP was modelled as the summation of risks associated to photon and neutron irradiation of radiosensitive organs. For the medium (>4Gy) and low dose regions, mechanistic and linear secondary cancer risks models were used, respectively. Two conformal and intensity-modulated prostate plans at 15MV (same prescription dose) were selected to illustrate the UCFCP features. RESULTS: UCFCP exhibits a bell-shaped behaviour with its maximum inside the therapeutic window. SCP values were not different for the plans analysed (∼2.4%) and agreed with published epidemiological results. Therefore, main differences in UCFCP came from differences in rectal NTCP (18% vs 9% for 3D-CRT and IMRT, respectively). According to UCFCP values, the evaluated IMRT plan ranked first. CONCLUSIONS: The level of SCP was found to be similar to that of NTCP complications which reinforces the importance of considering second cancer risks as part of the possible late sequelae due to treatment. Previous concerns about the effect of peripheral radiation, especially neutrons, in the induction of secondary cancers can be evaluated by quantifying the UCFCP.
Authors: Laura Ann Rechner; Arezoo Modiri; Line Bjerregaard Stick; Maja V Maraldo; Marianne C Aznar; Stephanie R Rice; Amit Sawant; Søren M Bentzen; Ivan Richter Vogelius; Lena Specht Journal: Acta Oncol Date: 2020-03-27 Impact factor: 4.089